Upcoming Medical Conferences in SwitzerlandSearch Criteria : Switzerland
Mar 05 - 06, 2019 | USD $2395 | Basel, Basel-Stadt
Pharma CI Europe Conference & Exhibition is organized by Pharma CI Conference and Exhibition and will be held from Mar 05 - 06, 2019 at Hyperion Hotel Basel, Basel, Basel-Stadt, Switzerland. Who Should Attend: You will benefit from attending this event if you are an executive or professional from the pharmaceutical, biotech, medical device and diagnostics industries with responsibilities or involvement in the following areas: Competitive Intelligence, Business Intelligence, Information Specialist, Commercial/Customer Insights, Strategic Planning, Market/Marketing Research, Decision Analysis/Decision Support, Business Analytics, New Product Planning/Development, Forecasting, Librarian, Brand Management/Product Management, Marketing, Business Portfolio Planning, Strategic/Business Analysis, Business Development, Licensing, Technical Analysis, Portfolio Management/Planning, Project Management, Risk Management, Research Planning, Research & Development, Regulatory, Scientist, Legal/Regulatory, Outsourcing, Manufacturing. Conference Description: This is the largest and best gathering of pharma, biotech, medical devices executives in competitive/ strategic/ business intelligence in the world! This anticipated gathering of industry elites will feature a program agenda led by a celebrated speaking faculty comprising 30+ pharma, biotech companies, about 50% of which are new to the conference. The Pharma CI Europe Conference will feature the involvement of the industry's most prominent companies, such as: Abbott, Acino International, Aimmune Therapeutics, Bayer, Celgene, Chiesi Farmaceutici, Debiopharm, Elanco, Fresenius Kabi, GSK, GW Pharmaceuticals, Helsinn Healthcare, IBM Watson Health, Idorsia Pharmaceuticals, Jazz Pharmaceuticals, Leo Pharma, Lonza, Merz, MSD, Novartis Pharma AG, Novo Nordisk A/S, Philips Healthcare, Roche, Sandoz, Sanofi, SOTIO, TESARO, UCB, Unither Pharmaceuticals, Vifor Pharma, and many more! You'll also hear from speakers from the most accomplished agencies and service providers. Each year this program agenda focuses on trending topics, industry innovations and both international and regional perspectives. Find out what insiders already know: the Pharma CI Conference is the best and largest conference series for competitive intelligence executives in pharma, biotech, and medical devices for 10+ Years. You'll see why this premier event is always the most talked-about and well-attended conference in the industry. Benefits of Attending: The Pharma CI Conference is the best-in-class conference for pharmaceutical, biotechnology, medical device, and diagnostic competitive intelligence executives. This conference has been established as the industry leader. • Unparalleled Networking: Meet hundreds of your peers from the US and around the world in one place at one time. There is no other place to meet all the established and emerging industry leaders in just two days. • Superior Speakers: Learn and discuss key industry news and challenges with 30+ senior level speakers. The depth of knowledge of our speaking faculty can’t be found anywhere else.| • Expansive Coverage: With over 30 sessions (presentations, panel discussions, table talks, and workshops), we cover every topic from top to bottom — from global industry macro issues to strategies to tactical issues in the US, Europe, China, and India. With so many parallels, concurrent sessions to choose from, each participant may tailor their agenda to fit their specific needs. So whether you’re a seasoned CI professional with 20 years of experience, or a new entrant to this field, your conference experience will be designed just for you. • Exclusive, High-Level Attendance: As the only truly focused Pharma Competitive Intelligence conference, we boast the most intimate setting of high-level executives. We have the highest ratio of industry practitioners (pharma biotech, medical device, and diagnostics) of any pharma intelligence conference, and we keep the setting casual and intimate. • Network Driven Sponsorships and Exhibition: We limit the exhibition hall to only the premier solution providers. Our limited capacity for exhibition ensures strong networking opportunities and a robust ROI. Every year industry practitioners meet with our vendors to find solutions to their current projects as well as to staff for their projected needs for the following year. For exhibitor & sponsorship opportunities, please see website/contact us via email or call +1-212-228-7974. Price: Delegate rates start from USD 1695.0 Speakers: Dr. Rachid BenHamza, Director Product Management, Commercial Operations, Helsinn Healthcare S.A., Daniel Cho, Head of Global Pricing and Competitive Portfolio Analytics, Philips PCMS, Jennifer Cummins, Director for Market Research and Competitive Insights, Vifor Pharma, Jacob Falck Hansen, Ph.D., Vice President, Head of Competitive Intelligence, Novo Nordisk A/S, Sara Panigone, Head of Global Competitive Intelligence, Corporate Marketing, Chiesi Farmaceutici, Dr. Pablo Prados, Senior Director, Integrated Care, Global Biologics Division, Sanofi, Nicolas PY, Director, Head of Market Intelligence & Group Strategic Committee Facilitator, Debiopharm International S.A., Alfred Reszka, Executive Director and Head, Strategic Business Intelligence, Merck/MSD, Dr. Heresh Rezavandi, BSc, MSc, Ph.D., Deputy Director, Bayer Consumer Care AG, Associate Director, Competitive Insights, Novartis Pharma AG, Associate Vice President, Proactive Worldwide, CEO, Molekule Consulting, Client Executive Life Sciences, IBM Watson Health, Co-founder, Dig Worldwide, Commercial Excellence and Business Development, TESARO, Deputy Director, Bayer, Director, RAS LSS Consulting, Director Business Development, Acino International, Director of Market Research & Competitive Insights, Vifor Pharma, Director Product Management, Helsinn Healthcare, Director, Business Analysis & Insight, Jazz Pharmaceuticals, Director, CMR Strategy & Project Office, Novo Nordisk A/S, Director, Head of Market Intelligence & Group Strategic Committee Facilitator, Debiopharm S.A., EU Senior Marketing Manager, Aimmune Therapeutics, General Market Intelligence Lead, CM/SM Center of Excellence, Global Enterprise Procurement, Johnson & Johnson Family of Companies, Global Head of Insights, Abbott Established Pharmaceuticals, Head Commercial International Markets, GW Pharmaceuticals, Head Global Business and Competitive Intelligence, Sandoz, Head of Business Analytics, Lonza, Head of Business Intelligence, SOTIO, a.s., Head of Global Competitive Intelligence, Chiesi Farmaceutici S.p.A., Head of New Product Planning, Leo Pharma, Junior Competitive Intelligence Advisor, Chiesi Farmaceutici S.p.A., Life Cycle Leader, Idorsia Pharmaceuticals, Managing Director, INOVIS, Market Analysis Manager, Unither Pharmaceuticals, Marketing Director, Merz, Portfolio Competitor Insights and Analytics Director, GlaxoSmithKline, Portfolio Strategy Manager, Elanco, President, Lifescience Dynamics, Senior Director, Integrated Care, Global Biologics Division, Sanofi, Senior Manager, Business Intelligence, Fresenius Kabi, Vice President Competitive Intelligence Diabetes, Novo Nordisk A/S Additional details will be posted as soon as they are available.
Mar 14 - 16, 2019 | CHF CHF650 | Bern, Bern
13th European Postgraduate Course in Neonatal and Paediatric Intensive Care Medicine is organized by BBS Congress GmbH and will be held from Mar 14 - 16, 2019 at University Children’s Hospital, Bern, Switzerland. Conference Topics: • Hemodynamics for the pediatric intensivist • Complications in the pediatric ICU • Handover - checklist or poetry • Postoperative analgo-sedation • Burnout and moral distress • Differences in drug use in the NICU • The ideal fluid for resuscitation • Treatment of neonatal abstinence syndrome • Bedside human milk analysis • CDH - Strategies before and after surgery • Palliative care / End of life in the PICU • Telemedicine in PICU • Pediatrics ARDS • Post CPR Care for children Additional details will be posted as soon as they are available.
Training series Practical insight Integrative gynecology by Cantonal Hospital St.Gallen / Kantonsspital St.Gallen
Mar 19, 2019 | St Gallen, Sankt Gallen
Training series Practical insight Integrative gynecology is organized by Cantonal Hospital St.Gallen / Kantonsspital St.Gallen and will be held on Mar 19, 2019 at Cantonal Hospital St. Gallen, St Gallen, Sankt Gallen, Switzerland. The target audience for this medical event is physicians of the Cantonal Hospital of St.Gallen as well as physicians in private practice, dipl. Nurses and therapists. Conference Description : Participants will gain insight into complementary and integrative medical concepts from Chinese and anthroposophic medicine, osteopathy and mind-body medicine. The day is practice-oriented and offers physicians the opportunity to discuss their own cases. Additional details will be posted as soon as they are available.
Apr 04, 2019 | CHF CHF130 | Bern, Bern
SGI Symposium 2019: In Focus: the Critically Ill Child - A Challenge for Adults Intensive Care ?! is organized by IMK Institute for medicine and communication Ltd and will be held on Apr 04, 2019 at Inselspital, Bern, Switzerland. Additional details will be posted as soon as they are available.
Apr 04, 2019 | CHF CHF500 | Basel, Basel-Stadt
AOTrauma Course - Intraoperative Imaging is organized by AOTrauma and will be held on Apr 04, 2019 at Basel, Basel-Stadt, Switzerland. Target audience: Orthopaedic surgery, Trauma surgery Additional details will be posted as soon as they are available.
Apr 04, 2019 | CME 2.00 | Lugano, Ticino
Direct Oral Anticoagulants (DOACs) is organized by Swiss Society of Intensive Medicine (SSMI) and will be held on Apr 04, 2019 at Regional Hospital of Lugano Civico, Lugano, Ticino, Switzerland. Credits: SGI-Credits: 2 Additional details will be posted as soon as they are available.
Apr 09 - 11, 2019 | EUR €2399 | Basel, Basel-Stadt
Practical Approaches to Quality and Development by Design (QDbD) for Robust Chemical Process is organized by Scientific Update Ltd and will be held from Apr 09 - 11, 2019 at Der Teufelhof Basel, Basel, Basel-Stadt, Switzerland. The target audience for this event is Organic Chemists - working in the pharmaceutical, pigment, agrochemical, explosives or fine chemicals industries, Development and Production Chemists, Chemical Engineers and Analysts. QDbD is no longer a regulatory initiative; because QDbD is good development, QDbD is an industry initiative supported by regulators. This course focuses on practical approaches to accelerated QDbD implementation, and it makes practical recommendations for realistic implementation of QDbD elements. Participants will learn how to prioritize process parameters for screening designs, how to design robust processes using statistical design of experiments (DoE), how to bridge the bench and the commercial design spaces using mixing and scale-up calculations, how to quantify process risk, how to select suitable process analytical technology tools (PAT) and more. Effective technology transfer to pilot and manufacturing plants is also discussed, including process validation in the QDbD. Benefits of Attending: • Prioritize process parameters prior to screening investigations • Design effective DoE screening matrixes • Design robust processes and assess key and critical process parameters • Execute key mixing and scale-up calculations to bridge the bench and the commercial design spaces • Use an equipment data base for effective technology transfer to pilot and manufacturing plants, and CMO’s • Estimate process risk • Make strategic decisions on PAT implementation Time: 9:00 am - 5:00 pm Price: Course fee: EUR 2399.0
Apr 10 - 13, 2019 | EUR €635.43 | Geneva, Geneva
ELCC 2019 - European Lung Cancer Congress is organized by European Society for Medical Oncology (ESMO), International Association for the Study of Lung Cancer (IASLC) and will be held from Apr 10 - 13, 2019 at Palexpo, Geneva, Switzerland. The target audience for this medical event is Medical oncologists, radiation oncologists, thoracic surgeons, respiratory physicians / pneumologists, interventional radiologists and pathologists all benefit from its comprehensive and stimulating programme. Conference Description: The European Lung Cancer Congress (ELCC) is a collaborative effort of the most important multidisciplinary societies representing thoracic oncology specialists, working together to advance science, disseminate education and improve the practice of lung cancer specialists worldwide. ELCC is now the point of reference in the field of thoracic malignancies. Since its inaugural edition in 2008, it has secured its status as the premier meeting for professionals in the field. ELCC is an annual event devoted to advance the quality of lung cancer treatment and find answers to unsolved problems which can contribute substantially to the improvement of patient survival. International experts in the field will discuss a full range of topics including: • I-O combinations and biomarkers • Molecular diagnostics and therapies • Early detection of lung cancer • Multidisciplinary treatment of locally advanced disease • Sequencing treatment in advanced disease • SCLC and mesothelioma Additional details will be posted as soon as they are available.
Apr 15 - 18, 2019 | Geneva, Geneva
18th International Conference on Preimplantation Genetics is organized by Preimplantation Genetic Diagnosis International Society (PGDIS) and will be held from Apr 15 - 18, 2019 at International Conference Center Geneva, Geneva, Switzerland. Additional details will be posted as soon as they are available.
May 05 - 10, 2019 | Les Diablerets, Waadt
Carbon Capture, Utilization and Storage Gordon Research Conference (GRC) is organized by Gordon Research Conferences (GRC) and will be held from May 05 - 10, 2019 at Eurotel Victoria Les Diablerets, Les Diablerets, Waadt, Switzerland. Additional details will be posted as soon as they are available.